NCT05085860

Brief Summary

The main purpose of this pilot project is to measure the feasibility of conducting a randomized crossover study examining short-term changes in atrial fibrillation (AF) symptoms in symptomatic females and males with paroxysmal or persistent AF when they engage in a standard week of exercise (i.e. moderate-intensity continuous training \[MICT\] or high-intensity interval training \[HIIT\]) compared to a control week (i.e. no moderate to vigorous exercise over 7 days).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable atrial-fibrillation

Timeline
11mo left

Started Feb 2022

Longer than P75 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Feb 2022Apr 2027

First Submitted

Initial submission to the registry

September 13, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 20, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

February 8, 2022

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

5.1 years

First QC Date

September 13, 2021

Last Update Submit

April 29, 2026

Conditions

Keywords

ExerciseSex differencesPilotSymptoms

Outcome Measures

Primary Outcomes (5)

  • Feasibility of the pilot study - Recruitment and consent rate

    Through study completion, an average of 1.5 years

  • Feasibility of the pilot study - Participant fidelity

    E.g. ability of participants to comply with the exercise prescription, number of exercise sessions attended

    During the week of HIIT and MICT (2 weeks)

  • Feasibility of the pilot study - Study retention

    Dropout rate of participants

    Through study completion, an average of 1.5 years

  • Feasibility of the pilot study - Study eligibility refinement

    Data to refine inclusion and exclusion criteria for a larger trial will be used by balancing safety, ability to complete the intervention, and generalizability (e.g. is an exclusion criterion of threshold of participation in \>2 structured exercise sessions/week sufficient or restrictive?)

    Through study completion, an average of 1.5 years

  • Feasibility of the pilot study - Adverse events

    Side effects and adverse events during the study

    Through study completion, an average of 1.5 years

Secondary Outcomes (2)

  • AF symptoms self-reported with a 7-day patient symptom questionnaire

    3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest)

  • AF status measured daily with a KardiaMobile device

    3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest)

Study Arms (3)

Moderate Intensity Continuous Training (MICT)

EXPERIMENTAL

Participants will do 3 sessions of moderate-intensity continous exercise training over 7 days

Behavioral: Moderate-intensity continuous training (MICT)

High Intensity Interval Training (HIIT)

EXPERIMENTAL

Participants will do 3 sessions of high-intensity interval training over 7 days

Behavioral: High-intensity interval training (HIIT)

Rest

NO INTERVENTION

Participants will abstain from doing moderate- to high-intensity interval training over 7 days

Interventions

Participants will engage in exercise and record AF symptoms prospectively over 7 days

Moderate Intensity Continuous Training (MICT)

Participants will engage in exercise and record AF symptoms prospectively over 7 days

High Intensity Interval Training (HIIT)

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Paroxysmal and Persistent AF
  • Rate controlled (resting ventricular rate \<110 bpm)
  • Able to do a symptom limited exercise test
  • At least 40 years of age
  • Self-reports being symptomatic in the past 4 weeks
  • If female, self-reports being post-menopausal
  • Able to read and understand English or French
  • Agrees to sign informed consent

You may not qualify if:

  • Currently participating in routine exercise training
  • Unstable angina or uncontrolled diabetes mellitus; or established diagnosis of severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy with significant obstruction
  • Unable to access the Internet or a phone (iPhone and iPad require iOS version 10.0 and up, Android requires version 6.0 and up) during the study period
  • Has an automated external defibrillator, an implantable cardioverter defibrillator or other types of pacemaker
  • Unwilling or unable to complete the three conditions
  • Unable to provide written, informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y4W7, Canada

RECRUITING

MeSH Terms

Conditions

Atrial FibrillationMotor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jennifer Reed, PhD

    Ottawa Heart Institute Research Corporation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This is a repeated measures randomized counter-balanced design. All participants will complete three conditions in a randomized order, with a wash-out week in between.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2021

First Posted

October 20, 2021

Study Start

February 8, 2022

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations